A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

NCT02218372 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile-associated Diarrhea (CDAD)

Interventions

DRUG: Fidaxomicin oral suspension
DRUG: Fidaxomicin tablets
DRUG: Vancomycin oral liquid
DRUG: Vancomycin capsules

Sponsor

Astellas Pharma Europe B.V.

Collaborators

[object Object]